Pathogenesis of antiphospholipid syndrome: understanding the antibodies. - Wikidata - wikimedia - TriplyDB

Pathogenesis of antiphospholipid syndrome: understanding the antibodies.

Pathogenesis of antiphospholipid syndrome: understanding the antibodies.

http://www.wikidata.org/entity/Q37873720

about

Vascular disease in systemic lupus erythematosus Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay Obstetrical antiphospholipid syndrome: from the pathogenesis to the clinical and therapeutic implications Catastrophic antiphospholipid syndrome: a clinical review Novel Phospholipid-Protein Conjugates Allow Improved Detection of Antibodies in Patients with Autoimmune Diseases Effect of Low Molecular Weight Heparins (LMWHs) on antiphospholipid Antibodies (aPL)-mediated inhibition of endometrial angiogenesis Diagnosis and management of catastrophic antiphospholipid syndrome.Antiphospholipid antibodies in iraqi women with recurrent mid-trimester abortions Current treatment of antiphospholipid syndrome: lights and shadows.Circulating Immune Complexes of IgA Bound to Beta 2 Glycoprotein are Strongly Associated with the Occurrence of Acute Thrombotic Events Antiphospholipid and antioangiogenic activity in females with recurrent miscarriage and antiphospholipid syndrome.The role of platelets in antiphospholipid syndrome.Serum Protein Profile in Women With Pregnancy Morbidity Associated With Antiphospholipid Syndrome.Recurrent pregnancy loss: current perspectives Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers.Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS.Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome.Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management.Presence of autoantibody against two placental proteins, peroxiredoxin 3 and peroxiredoxin 4, in sera of recurrent pregnancy loss patients.Activated protein C resistance and antiphospholipid antibodies in recurrent fetal loss: experience of a single referral center in northern iraq A polymorphism in TLR2 is associated with arterial thrombosis in a multiethnic population of patients with systemic lupus erythematosus.A role for uric acid and the Nalp3 inflammasome in antiphospholipid antibody-induced IL-1β production by human first trimester trophoblast.Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice.Association of early kidney allograft failure with preformed IgA antibodies to β2-glycoprotein I.An A1-A1 mutant with improved binding and inhibition of β2GPI/antibody complexes in antiphospholipid syndrome.Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I.Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches.Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss.LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers The complement system at the embryo implantation site: friend or foe?Identification of a Monoclonal Antibody That Attenuates Antiphospholipid Syndrome-Related Pregnancy Complications and Thrombosis.Progesterone and autoimmune disease.Evaluation of the Clinical Performance of a Novel Chemiluminescent Immunoassay for Detection of Anticardiolipin and Anti-Beta2-Glycoprotein 1 Antibodies in the Diagnosis of Antiphospholipid Syndrome.Effect of prednisone, aspirin, low molecular weight heparin and intravenous immunoglobulin on outcome of pregnancy in women with antiphospholipid syndrome.ApoE Receptor 2 Mediation of Trophoblast Dysfunction and Pregnancy Complications Induced by Antiphospholipid Antibodies in Mice Evaluation of the diagnostic potential of antibodies to beta2-glycoprotein 1 domain 1 in Chinese patients with antiphospholipid syndrome Anticoagulation in management of antiphospholipid antibody syndrome in pregnancy.Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers.Thrombotic antiphospholipid syndrome shows strong haplotypic association with SH2B3-ATXN2 locus.Detection of multiple annexin autoantibodies in a patient with recurrent miscarriages, fulminant stroke and seronegative antiphospholipid syndrome.

P2860

Q21285155-49095FB4-4CB1-4DB8-98E7-FA7E33068938 Q26739950-18EE3D45-5F61-4678-9183-62E4E391C7EB Q26998188-CC896E1C-4FD3-4898-ACE9-EC145CE08514 Q27009935-486C89C8-0F51-4E39-8DD7-9126F88601AD Q28552664-4E610503-E19F-4C03-8E6F-9CF5B2A447B6 Q28740531-6DAD9158-CB40-4B3D-9418-B0FFDF015BC7 Q30235356-14FD683A-E6F0-4227-9BF2-D19AA3B87200 Q33406095-5C6BA23D-076B-4D09-857F-014354A4B7DB Q33423959-F797382B-D260-44E5-AC2E-E9FFF3C9FCFC Q33431396-679DD820-3AF0-41B6-BCBC-EB7FD1F60022 Q33435408-13553B53-FA8C-4B3A-AC1A-1DFEBD29D467 Q33439904-EEAE8BDF-2413-4D62-9AF4-12BF2A049C27 Q33604935-47A13EE7-E7F2-43A4-8FB7-E5EA990761FC Q33713930-34221CD9-E863-43F7-A716-0C3AC4C58895 Q33766670-BBF9A39E-8B6B-4F32-A124-486C79DC531E Q33948737-8609D343-2710-4E06-9B3F-F573B46EB9E9 Q34287356-79B2DCBA-F880-4B88-BAE7-9B72D0B72635 Q34476952-EF658E0C-D57C-401E-8E5F-EDD9B6B0875E Q34494348-B2EE1C64-5DAD-43C9-B390-9043D82FD628 Q34569019-D4EB9C51-7A8A-4559-BC51-855A135DC5AA Q34722499-5737F2AB-2782-40CE-BC5D-E1DCC4EC4DF1 Q34769721-8014E1EB-A3F1-4F4B-9957-BE133F8A9AED Q35070716-11F978C3-18E1-461F-8C6F-52E1E8BD416C Q35124252-14B821DE-D0AF-4414-81BA-D70BB7FD23DD Q35152055-858F8474-B6ED-4B6B-B7C2-7DEF904B59E6 Q35419865-807B0B29-4595-4908-B39F-3868F2CFAF03 Q35621012-8BAA43EF-886C-47CA-9C96-83963780903B Q35854768-85AE7B4E-D9D4-4B38-B8F1-B3BB8522AC37 Q35907083-7E9AEC26-20E5-4A47-9B02-14963AD624E4 Q35927443-9AFE97FE-216F-4FF1-B21B-5E13A6689F59 Q36087118-7247F533-BE8A-4C9A-B8A0-186E1DC8A8EA Q36202227-B4B9898B-1460-4B9E-90F1-CC30F699AAFF Q36299310-EAD8674E-DEBE-4E0C-9DA8-A2798C126DB3 Q36472439-72737F91-2A47-4FD6-A558-B6468E9A0D5C Q36619367-FB71E7FD-2349-4BE9-A903-5A07C1C2D786 Q36774243-4AD2A7DC-3703-4CE7-B851-5C9EB9303E00 Q36879113-1D93A0CC-71F4-4BDF-94EC-E7DD59C4C560 Q36923241-73279A45-E784-46B7-A6A9-E2D32A76BCD5 Q36981341-D6AE7301-DE2A-4D53-B9CB-AE3F40ADCF11 Q37011051-0B079BD9-E7CB-45BF-B700-0B6A3B658F4B

P2860

Pathogenesis of antiphospholipid syndrome: understanding the antibodies.

http://www.wikidata.org/entity/Q37873720

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 May 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pathogenesis of antiphospholipid syndrome: understanding the antibodies.

@en

Pathogenesis of antiphospholipid syndrome: understanding the antibodies.

@nl

type

label

Pathogenesis of antiphospholipid syndrome: understanding the antibodies.

@en

Pathogenesis of antiphospholipid syndrome: understanding the antibodies.

@nl

prefLabel

Pathogenesis of antiphospholipid syndrome: understanding the antibodies.

@en

Pathogenesis of antiphospholipid syndrome: understanding the antibodies.

@nl

P1433

Q37873720-803F50C7-FD06-4C83-AEEE-F3FF1CBACCA7

P1476

Q37873720-CA2BFEE5-5187-4DD6-A87E-C3531CD05B1F

P2093

Q37873720-2A980863-BC71-446A-9FD6-050983BA0FC1

Q37873720-2B294D4F-43D4-40C3-8F38-4627FE5D3ECE

Q37873720-80C24649-4A0C-4148-9AD6-FA320270F4FB

P2860

Q37873720-05936FE3-CD55-436B-AD3F-CF2D4366EDB4

Q37873720-0D13A4FC-6AAF-4EA4-8B76-1CADCCAFBAB9

Q37873720-1809F18F-7B9E-49B9-852A-869CD1361906

Q37873720-1CFE7FA3-804E-4782-9488-8B0077C5E4D0

Q37873720-207E6A43-9166-4031-8B70-826E24E04D32

Q37873720-24698B8F-BCF2-45B2-9C16-6206BC35C09D

Q37873720-2505BBAC-D720-4349-AA2D-0A3BDC511562

Q37873720-265BC646-5314-4927-9F5B-60E7419C9B83

Q37873720-285D0571-549E-48F0-A804-C5D04142A863

Q37873720-2CD9ADAC-81E1-459F-BA93-F9FFD1173596

P2888

Q37873720-3F3DC24B-B38F-4BF9-9E7E-CBACBC8DFC8D

P304

Q37873720-9E116791-838D-4214-BC77-490F98F677C1

P31

Q37873720-365774E7-DE9C-4137-8B44-36B636AD94E9

P356

Q37873720-EAE8EE12-7D20-433C-BBA4-CDD1AF3C2FEF

P407

Q37873720-B45BDCAC-F480-4B14-A351-46EA03B8A496

P433

Q37873720-55998BB3-323B-42BD-A8E7-854A6E44F701

P478

Q37873720-AB344903-19C8-43D6-8707-B35013F17308

P50

Q37873720-8745255F-BEA8-4841-BCB5-0B62B492BC16

P577

Q37873720-8B35F398-EFC3-4526-A876-5BE9F62A21C3

P5875

Q37873720-CB9093E7-878C-4812-9C28-A26318F4A972

P6179

Q37873720-21566395-4A54-40B2-BBAE-6FD847FDFB54

P698

Q37873720-AA4EC974-3ACB-4110-B134-FE71844AC61F

P921

Q37873720-D3E99DC8-F26D-495C-8FF9-3050E5F6E341

Q37873720-EC5B6F1F-ACE6-4CDC-A108-52499162D480

P356

NRRHEUM.2011.52

P1433

Nature Reviews Rheumatology

P1476

Pathogenesis of antiphospholipid syndrome: understanding the antibodies.

@en

P2093

Elena Raschi

http://www.w3.org/2001/XMLSchema#string

Francesco Tedesco

http://www.w3.org/2001/XMLSchema#string

M Orietta Borghi

http://www.w3.org/2001/XMLSchema#string

P2860

Reelin and apolipoprotein E receptor 2 in the embryonic and mature brain: effects of an evolutionary change in the apoER2 gene

Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells

Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor

Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2.

Functional proteomics: examining the effects of hypoxia on the cytotrophoblast protein repertoire.

Complement C3 activation is required for antiphospholipid antibody-induced fetal loss.

E-Selectin mediates pathogenic effects of antiphospholipid antibodies.

Phospholipid binding plasma proteins required for antiphospholipid antibody detection--an overview.

P2888

nrrheum.2011.52

P304

330-339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRRHEUM.2011.52

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Pier Luigi Meroni

P577

2011-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51111206

http://www.w3.org/2001/XMLSchema#string

P6179

1049967834

http://www.w3.org/2001/XMLSchema#string

P698

21556027

http://www.w3.org/2001/XMLSchema#string

P921